Anti-LXR alpha antibody [EPR6508(N)] (ab176323)
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [EPR6508(N)] to LXR alpha
- Suitable for: Flow Cyt, WB, ICC/IF
- Reacts with: Human
Overview
-
Product name
Anti-LXR alpha antibody [EPR6508(N)]
See all LXR alpha primary antibodies -
Description
Rabbit monoclonal [EPR6508(N)] to LXR alpha -
Host species
Rabbit -
Tested Applications & Species
See all applications and species dataApplication Species Flow Cyt HumanICC/IF HumanWB Human -
Immunogen
-
Positive control
- Human fetal liver, Jurkat and MCF-7 cell lysates. Jurkat cells and MCF7 cells.
-
General notes
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. -
Storage buffer
pH: 7.20
Preservative: 0.01% Sodium azide
Constituents: 9% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA, 50% Tissue culture supernatant -
Concentration information loading...
-
Purity
Protein A purified -
Clonality
Monoclonal -
Clone number
EPR6508(N) -
Isotype
IgG -
Research areas
- Epigenetics and Nuclear Signaling
- Nuclear Signaling Pathways
- Nuclear Receptors
- Orphan Nuclear Receptors
- Metabolism
- Pathways and Processes
- Metabolic signaling pathways
- Lipid and lipoprotein metabolism
- Lipid metabolism
Images
-
All lanes : Anti-LXR alpha antibody [EPR6508(N)] (ab176323) at 1/1000 dilution
All lanes : Human SCC61 whole cell lysates
Lysates/proteins at 23 µg per lane.
Secondary
All lanes : Rabbit anti-rabbit polyclonal HRP conjugate at 1/3000 dilution
Developed using the ECL technique.
Performed under reducing conditions.
Predicted band size: 50 kDa
Additional bands at: 100 kDa (possible non-specific binding)
Exposure time: 1 secondFrom left to right lanes 1 - 3. Blocking was done with 5% milk in PBS incubated for 1 hour at 22°C.
-
All lanes : Anti-LXR alpha antibody [EPR6508(N)] (ab176323) at 1/1000 dilution
Lane 1 : Human fetal liver lysate
Lane 2 : Jurkat cell lysate
Lane 3 : MCF7 cell lysate
Lysates/proteins at 10 µg per lane.
Predicted band size: 50 kDa
-
Immunofluorescent staining of Jurkat cells labeling LRX alpha using ab176323 at a 1/50 dilution.
-
Flow cytometric analysis of permeabilized MCF-7 cells labeling LXR alpha using ab176323 at a 1/10 dilution (red) or a rabbit IgG control (green).
-